Search

The paper presents a analysis of quantitative and qualitative dimensions of global research output (3488 records) on "Impact of COVID-19 on Children and Adolescents", based on indexed publications in Scopus database. The global publications on this theme averaged 8.31 citations per paper. About 1.49% share of its total publications in this area received external funding support. The 145 countries partcipitated in global research output on "Impact of COVID-19 on Children and Adults", of which the top 10 countries accounted for 85.21% and more than 100% share of global publications and citations. The USA, U.K. and Italy leads in global publications ranking and productivity as against China (3.16), U.K (1.28) and USA (1.27) leading in terms of relative of relative citation index. The 412 organizations and 661 authors participated in global research on this theme, with top 15 most productive organizations and authors contributing 21.07% and 4.30% global publications share and 38.05% and 12.98% global citations share. Harvard Medical School, USA, Huazhong University of Science and Technology, China and Tongji Medical College, China leads the world as the most productive organizatons (with 480, 67 and 63 publications) and Huazhong University of Science and Technology, China (31.97 and 3.85), Tongji Medical College, China (19.92 and 2.40) and Children Hospital of Philadelphia, USA (19.30 and 2.32) leading as the most impactful organizations in the world in terms of citation per paper and relative citation index. D.Buonsensov, C.Calvo and X. Lu were the most productive authors (with 15, 12 and 12 papers) and X.Lu (103.83 and 12.49), A. Licari ( 40.11 and 4.83) and G.L. Marseglia( 34.09 and 4.1) were the most impactful authors. JAMA Pediatrics, Pediatrics Infectious Disease Journal and Acta Paediatrica International Journal of Pediatrics were the most productive journals (with 71, 60 and 58 papers) and Pediatrics (36.59, JAMA Pediatrics (19.49) and Acta Paediatrica International Journal of Pediatrics (14.93) were the most impactful journals. [ABSTRACT FROM AUTHOR]

The study aims to evaluate global research output (103054 records) on coronavirus disease (COVID-19) based on quantitative and qualitative indicators. It presents a bibliometric profile of most influential countries, organizations, authors and journals and their collaborative linkages, besides identifying broad subject areas of research, most significant keywords and highly-cited papers related to COVID-19. During 2020-21, more than 150 countries participated in COVID-19 research, of which top 10 countries accounted for a 82.93% global share. The USA, China and U.K. produced the most articles (25.86%, 10.77% and 10.7% respectively). The top three organizations, namely Harvard Medical School, USA, Huazhong University of S&T, China and Tongji Medical College, China contributed 1755, 1344 and 1267 papers, respectively. The most cited organizations in COVID-19 research are: Peking Union Medical College, China (97.41 CPP), University of Hong Kong (82.17 CPP) and Renmin Hospital of Wuhan University, China (59.88 CPP). The top three most productive authors are: V. Wanitlit, E. Mahase and G. Lacobucci (with 152, 135 and 108 papers). The top three most cited authors in terms of citations per paper (CPP) are: Y. Hu (319.82), L. Liu (303.91) and J.F.W. Chan (169.55). The most productive organizations originate from most productive countries and they contribute the most collaborative papers. The top three journals, namely International Journal of Environmental Research, BMJ and PLOS One contributed 961, 854 and 781 papers, respectively. The top three journals in terms of citations per paper (CPP) are New England Journal of Medicine (122.78), The Lancet (106.3) and JAMA (75.17). The most ubiquitous topic was COVID-19 clinical studies, with maximum focus on virological aspects (9.58%), respiratory aspects (6.97%), molecular aspects (3.11%), genetic aspects (3.09%) and immunological aspects (1.3%). The results of this study should be of interest to working scientists, clinicians and policy-makers in improving their understanding of COVID-19 disease and in its management. [ABSTRACT FROM AUTHOR]